CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 3,498 shares at $23.65 ($82,728)
- 4 Open-market sale Director sold 1,600 shares at $25.98 ($41,560)
- 4 Planned sale EVP, CHIEF FINANCIAL OFFICER sold 22,000 shares at $25.18 ($554,024)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Open-market sale Director sold 14,446 shares at $21.78 ($314,634)
- 144 Insider Sale of Securities
- 4 Option exercise Director acquired 9,387 shares (option exercise)
- 4 Option exercise Director acquired 9,387 shares (option exercise)
- 4 Option exercise Director acquired 9,387 shares (option exercise)
- 4 Option exercise Director acquired 9,387 shares (option exercise)
- 4 Option exercise Director acquired 9,387 shares (option exercise)
- 4 Option exercise Director acquired 9,387 shares (option exercise)
- 4 Grant or award Director acquired 32,428 shares (grant or award)
Page 4 of 70 · 1,382 filings